Latest Period
n/a
Security Snapshot
Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) Institutional Ownership
CUSIP: G1281K122
13F Institutional Holders and Ownership History from Q4 2024 to Q3 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.88
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary shares, par value $0.0135 per share
- Symbol
- SLXN on Nasdaq
- Shares outstanding
- 3,320,313
- SEC-reported price per share
- $0.88
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share is tracked under CUSIP G1281K122.
- Latest finished 13F holder period is not available.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 6 to 0 between Q2 2025 and Q3 2025.
- SEC-reported value moved from $228,588 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
G1281K122
Latest holder period
n/a
13F holders
13D/G owners
6
CIK / CUSIP context first
SLXN full holder history
Silexion Therapeutics Corp SEC filings
Silexion Therapeutics Corp company facts
Silexion Therapeutics Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G1281K122:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
SLXN
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 4.9% | -40% | $424,574 | +$109,304 | 456,531 | +35% | CVI Investments, Inc. | 31 Mar 2025 |
| Lind Global Fund III LP | 6.4% | -35% | $187,000 | -$10,164 | 212,500 | -5.2% | Lind Global Fund III LP | 30 Sep 2025 |
| GOLDMAN SACHS GROUP INC | 2.4% | -60% | $197,109 | +$92,724 | 211,945 | +89% | THE GOLDMAN SACHS GROUP, INC. | 31 Mar 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | $195,139 | 209,827 | Mitchell P. Kopin | 15 Jan 2025 | |||
| Lincoln Alternative Strategies LLC | 6.2% | $115,500 | 131,250 | Lincoln Alternative Strategies LLC | 12 Sep 2025 | |||
| Wildcat Capital Management, LLC | 1.3% | $108,891 | 113,428 | Wildcat Capital Management, LLC | 26 Jun 2025 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Latest
n/a
Rows shown
1-4 of 4